[ad_1] Image source: Getty Images The Rolls-Royce (LSE RR) share price recovery is one for the ages. When Tufan Erginbilgic took charge in January 2023 he publicly derided the FTSE 100 engineering group as a “burning platform”. At this point…
[ad_1] AlphaStreet Newsdesk powered by AlphaStreet Intelligence United Rentals surged 5.7% Wednesday as UBS raised its price target by double digits, citing strengthening fundamentals in the equipment rental giant. Shares hit $1051.68 on volume of 411,276 shares, adding to the…
[ad_1] Image source: Getty Images Investors targeting a second income from the stock market will know all about the benefits of dividend shares. But not all shares are made the same. A high yield looks tempting, yet without sufficient earnings…
[ad_1] AlphaStreet Newsdesk powered by AlphaStreet Intelligence Sandisk Corporation surged 6.7% Wednesday to $1831.79 after three major Wall Street firms upgraded the stock and raised price targets by an average of 44.4%, signaling fresh confidence in the computer hardware maker’s…
[ad_1] Image source: Getty Images Howden Joinery (LSE: HWDN) is among the FTSE 100’s top performers today (3 June) after agreeing to acquire online kitchen retailer DIY Kitchens in a £390m deal. The move marks an unusual step for the…
[ad_1] Why Cisco is not just an AI trade Cisco (CSCO) is easy to reduce to whichever narrative is loudest at the moment. Right now that is AI infrastructure. But the company’s own filings suggest the sturdier thesis is broader:…
[ad_1] Image source: Getty Images Rolls-Royce (LSE: RR.) shares have turned £4,160 — or just £80 saved per week — into more than £48,000 in the past five years. That’s a gain of more than 1,115% and ranks among the…
[ad_1] Why Brown & Brown is not just an insurance-cycle stock Brown & Brown (BRO) can get lumped in with insurers whenever the market starts debating premium rates or catastrophe pricing, but that framing misses what the company actually does.…
[ad_1] Image source: Getty Images I invest in my portfolio of UK and global shares at every opportunity. Why? Not doing so leaves me in danger of retirement poverty. That might sound sensational. But new research today (3 June) shows…
[ad_1] Why Edwards is more than a single-product medtech story Edwards Lifesciences (EW) is often discussed as if it were mainly a TAVR company. That shorthand is understandable because transcatheter aortic valve replacement remains its largest business. But the company’s…